Giulia Rovesti

777 citations
27 papers · 393 indexed · h-index 11
Topics
Hepatocellular Carcinoma Treatment and Prognosis (7 papers)Cancer, Lipids, and Metabolism (7 papers)Pancreatic and Hepatic Oncology Research (5 papers)
Partner nations
ItalyUnited StatesSweden

In The Last Decade

Giulia Rovesti

25 papers receiving 390 citations

Peers

Giulia Rovesti
Comparison fields: 5 of 67
  • Oncology 162
  • Molecular Biology 123
  • Hepatology 88
  • Cancer Research 85
  • Epidemiology 70
Replace Kazuyoshi Hirayama with:
Kazuyoshi Hirayama Japan
Yu-Min Liao Taiwan
Jing‐Yun Wen China
Chan Xie China
Monica Capozzi Italy
Zhi-Qiang Meng China
Elisa Tassinari Italy
Qianqian Zhang China
Yuichiro Uchida Japan
Adelaida La Casta Spain
Giulia Rovesti relative to Kazuyoshi Hirayama Japan Kazuyoshi Hirayama's profile →
Citations per field
00.5×3.7×
Kazuyoshi Hirayama · 1×
Citations per year

Countries citing papers authored by Giulia Rovesti

Since Specialization
Citations

This map shows the geographic impact of Giulia Rovesti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Rovesti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Rovesti more than expected).

Fields of papers citing papers by Giulia Rovesti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Rovesti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Rovesti. The network helps show where Giulia Rovesti may publish in the future.

Co-authorship network of co-authors of Giulia Rovesti

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Rovesti. A scholar is included among the top collaborators of Giulia Rovesti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Rovesti. Giulia Rovesti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 10
5 9
6 0
7 43
8 3
9 16
10 9
11 11
12 13
13 21
14 7
15 22
16 1
17 61
18 1
19 43
20 49

About Giulia Rovesti

Giulia Rovesti is a scholar working on Hepatology, Cancer Research and Oncology, having authored 27 papers that have together received 393 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer, Lipids, and Metabolism (7 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Hepatology (88 citations), Oncology (162 citations) and Cancer Research (85 citations). Giulia Rovesti has collaborated with scholars based in Italy, United States and Sweden. Frequent co-authors include Andrea Casadei‐Gardini, Giulia Orsi, Massimo Dominici, Francesco Giuseppe Foschi, Alessandra Recchia, Edwin M. Horwitz, Margherita Rimini, Elena Veronesi, Giulia Grisendi and Filippo Rossignoli. Their work appears in journals such as Gut, Journal of Hepatology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026